News & Updates
Showing Multidisciplinary articles
Showing
Hypocalcaemia tied to mid-, long-term death in acute pulmonary thromboembolism
Low serum calcium in patients with acute pulmonary thromboembolism (PTE) independently predicts 30-day and long-term mortality, suggests a China study that used a new prognosis assessment model.
Hypocalcaemia tied to mid-, long-term death in acute pulmonary thromboembolism
30 Aug 2022
Inflammatory diet ups NAFLD risk, especially in men
A dietary pattern with high inflammatory potential appears to increase the risk of nonalcoholic fatty liver disease (NAFLD), reports a study, adding that this association is greater in men.
Inflammatory diet ups NAFLD risk, especially in men
30 Aug 2022
Healthy eating, working out promote longevity in PD patients
Parkinson’s disease (PD) patients who follow a healthy diet and engage in physical activity appear to fare well, with a recent study showing that both lifestyle behaviours cut the risk of all-cause mortality.
Healthy eating, working out promote longevity in PD patients
30 Aug 2022
Latest glucose-lowering drug use and glycaemic outcome trends in HK
A retrospective cross-sectional analysis of trends in glucose-lowering drug (GLD) use and glycaemic outcomes among Hong Kong’s 0.9 million adults with diabetes between 2002 and 2019 finds a levelling off in improvements since 2014.
Latest glucose-lowering drug use and glycaemic outcome trends in HK
30 Aug 2022
RYGB in severe obesity leads to weight loss, hypertension remission
In patients with severe obesity, undergoing either laparoscopic sleeve gastrectomy (LSG) or laparoscopic Roux-en-Y gastric bypass (RYGB) resulted in weight loss, according to long-term follow-up of the SLEEVEPASS* trial. However, remission of hypertension was more likely in patients who underwent RYGB compared with LSG.
RYGB in severe obesity leads to weight loss, hypertension remission
29 Aug 2022
Combined oral contraceptives and VTE: Which pill conveys the highest risk in young women?
Combined oral contraceptives (COCs) that contain gestodene confer a fivefold increased risk of venous thromboembolism (VTE) in young women as compared with those that contain levonorgestrel and the lowest doses of ethinylestradiol, as shown in a study.